These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1843653)

  • 21. Population genetics and molecular epidemiology of Neisseria meningitidis.
    Caugant DA
    APMIS; 1998 May; 106(5):505-25. PubMed ID: 9674888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey.
    Dinleyici EC; Ceyhan M
    Expert Rev Vaccines; 2012 May; 11(5):515-8. PubMed ID: 22827237
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active surveillance of meningococcal meningitis in Poland.
    Tyski S; Grzybowska W; Lind I
    Cent Eur J Public Health; 1998 Aug; 6(3):219-24. PubMed ID: 9787924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.
    Commun Dis Intell; 1999 Nov; 23(12):317-23. PubMed ID: 10615794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for control of meningococcal disease. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Ottawa, Ontario, Canada.
    Can Commun Dis Rep; 1994 Feb; 20(3):17-27. PubMed ID: 8167604
    [No Abstract]   [Full Text] [Related]  

  • 27. [Meningococcus, serogroup C].
    Noack R
    Krankenpfl J; 2005; 43(1-3):16. PubMed ID: 15912812
    [No Abstract]   [Full Text] [Related]  

  • 28. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningococcal meningitis following rifampin prophylaxis.
    Khuri-Bulos N
    Am J Dis Child; 1973 Nov; 126(5):689-91. PubMed ID: 4200808
    [No Abstract]   [Full Text] [Related]  

  • 30. [Towards the universal protection of meningococcus: state-of-the-art of new vaccines].
    Esposito S; Serra D; Gualtieri L; Cesati L; Preti V; Principi N
    Minerva Pediatr; 2009 Dec; 61(6):739-42. PubMed ID: 19935538
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningoencephalitis and septicemia caused by Neisseria meningitidis. Clinical, bacteriolgical, and histopathological experiences].
    Valenzuela MT
    Salud Publica Mex; 1975; 17(4):511-5. PubMed ID: 812187
    [No Abstract]   [Full Text] [Related]  

  • 33. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A controlled trial with 2 anti-Neisseria B meningitidis vaccines and placebo in Chilean population].
    Herrera P; Lagos R
    Rev Med Chil; 1998 Nov; 126(11):1403-4. PubMed ID: 10349187
    [No Abstract]   [Full Text] [Related]  

  • 35. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The meningococcal vaccine--public policy and individual choices.
    Offit PA; Peter G
    N Engl J Med; 2003 Dec; 349(24):2353-6. PubMed ID: 14668463
    [No Abstract]   [Full Text] [Related]  

  • 39. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology and clinic of meningococcal infections. Indications for immunization].
    Goetz O; Peller P
    MMW Munch Med Wochenschr; 1980 Oct; 122(41):1411-2. PubMed ID: 6780820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.